Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53

Journal of the National Cancer Institute

Volumn 92, Issue 13, 2000, Pages 1088-1091

  Werness, Bruce A ^a,g   Parvatiyar, Pankhuri ^a   Ramus, Susan J ^c   Whittemore, Alice S ^d   Garlinghouse Jones, Kim ^d   Oakley Girvan, Ingrid ^d   DiCioccio, Richard A ^a   Wiest, Jonathan ^b   Tsukada, Yoshiaki ^f   Ponder, Bruce A J ^c   Piver, M Steven ^e  

^a Department of Pathology ^*  (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f Sisters Hospital   (United States)

^g UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME MICRODISSECTION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MEDICAL DOCUMENTATION; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; STROMA CELL; TUMOR SUPPRESSOR GENE;

EID: 0034608767     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.13.1088     Document Type: Article

References (24)

1. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
2. Wetness BA. Piver MS. Allen HI, et al. Mutation analysis of BRCA1. TP53, and KRAS2 in ovarian and related pelvic tumors
3. Correlation of TP53 mutations and p53 expression in ovarian tumors
4. Germline mutations of the BRCA1 gene in breast and ovariancer families provide evidence for a genotype-phenotype cancer families provide evidence for a genotype-phenotype correlation
5. Mutation and cancer: Statistical study of retinoblastoma
6. Mutation analysis of the BRCA1 gene in ovanian cancers
7. Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: Four germline mutations, but no evidence of somatic mutation
8. BRCA1 mutations in primary breast and ovarian carcinomas
9. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer
10. Mutational analysis of BRCA1 gene in ovarian and breast-ovarian cancer families in Japan
11. Early de novo ovarian carcinoma. A study of fourteen cases
12. Alteration of p53 gene in ovarian carcinoma: Clinicopathological correlation and prognostic significance
13. TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas
14. Mutation and overexpression of p53 in early-stage epithelial ovarian cancer
15. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer
16. Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer
17. Prognostic significance of p53 immunostaining in epithelial ovarian cancer
18. P53 gene mutations and protein accumulation in human ovarian cancer
19. P53 expression in ovarian borderline tumors and stage I carcinomas
20. P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significance
21. p53 allelotypes and enhanced detection of allelic loss in ovarian cancer: Lack of correlation with familial and clinical factors
22. The tumor suppressor genes
23. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers
24. Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours